跳至主要内容
临床试验/NCT05280366
NCT05280366进行中(未招募)不适用

A Prospective, Randomized, Multi-center Evaluation of the Safety and Effectiveness of the STREAMLINE®SURGICAL SYSTEM Compared to iStent Inject W® in Patients With Open-Angle Glaucoma

New World Medical, Inc.20 个研究点 分布在 3 个国家目标入组 150 人开始时间: 2022年2月9日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
150
试验地点
20
主要终点
Change in mean unmedicated diurnal Intraocular Pressure (IOP)

研究概览

简要总结

A study of the Streamline Surgical System versus competitor

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Diagnosis of Mild to Moderate Primary Open Angle Glaucomma

排除标准

  • •Other types of glaucoma including but not limited to: Normal tension glaucoma, pseudoexfoliative glaucoma, narrow angle glaucoma, traumatic, congenital, malignant, uveitic or neovascular glaucoma. Ocular hypertension.

研究组 & 干预措施

Streamline Surgical System

Other

Streamline Surgical System procedure administered

干预措施: Streamline Surgical System (Device)

iStent Inject W

Active Comparator

iStent Inject W implanted

干预措施: iStent Inject W (Device)

结局指标

主要结局

Change in mean unmedicated diurnal Intraocular Pressure (IOP)

时间窗: 24 months

Change in mean unmedicated diurnal Intraocular Pressure (IOP) over time

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (20)

Loading locations...

相似试验